Current financial headlines
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
Sharemaestro Market Watch Weekly signal
The diagnostics stock’s latest weekly move extended a sharp three-month advance, with turnover running above its recent average.
Chronological news
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
EdgePoint Investment Group Inc. has filed an amended Schedule 13G, disclosing a 4.21% beneficial ownership stake in Twist Bioscience Corp (TWST), totaling 2,521,635 shares as of June 30, 2026. The filing indicates EdgePoint acts as an investment manager for various funds that directly own …
Brown Shipley & Co Ltd has acquired 10,509 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $5.27 million, making it their 11th largest holding. Thermo Fisher Scientific recently reported strong quarterly earnings, exceeding analyst estimates with an EPS of $6.03 and revenue …
Assenagon Asset Management S.A. increased its stake in Quest Diagnostics Incorporated by 39.1% in the second quarter, acquiring 4,334 shares and bringing its total holdings to 15,405 shares valued at approximately $3.27 million. The medical research company reported strong Q2 earnings, exceeding estimates with …
Thermo Fisher Scientific and KYAN Technologies have signed an MoU to advance functional precision oncology for solid tumours. The collaboration will use patient-derived tumoroid models, functional drug-response screening, and genomic analysis to gather patient-relevant data across various cancers, aiming to improve therapeutic decision-making. They …
Envetec Senior Thermo Fisher Scientific executive brings nearly 30 years of healthcare and commercial leadership to support Envetec's global expansion Patrick S. JonesPatrick S. Jones, President of Thermo Fisher Scientific's Clinical Diagnostics Division and independent director of Envetec Sustainable Technologies BIRDHILL, Ireland, Aug. 14, …
5 Insightful Analyst Questions From Charles River Laboratories's Q2 Earnings Call Charles River Laboratories' second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management highlighted that the rebound was most evident in the Discovery and Safety Assessment (DSA) …
METTLER TOLEDO Product Inspection Group has launched its new LightningBuild program, offering a four-week delivery time for select product inspection systems. The program currently includes the X12 LightningBuild x-ray inspection system and the C31 LightningBuild checkweigher, designed to help food and pharmaceutical manufacturers quickly …
When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma …
Astorg Partners has acquired Thermo Fisher Scientific's global microbiology business for $1.075 billion, creating an independent diagnostics company focused on microbial testing. The newly independent entity, which will operate under a new brand and CEO Dirk Bontridder, manufactures consumables and instruments for identifying and …
The precision-oncology diagnostics stock remains in an active weekly Trend Signal, but lighter participation and a wide fair-value premium make confirmation the next test.
DODGE & COX has significantly increased its holdings in THERMO FISHER SCIENTIFIC (TMO) by adding 3,029,037 shares, as revealed in a recent SEC 13F filing for the Q2 2026 report period. This move comes amidst varied institutional investor activity, with some firms adding and …
Birgit Girshick, CEO of Charles River Laboratories International (NYSE:CRL), sold 6,500 shares of the company's stock for approximately $1.82 million. This transaction, executed under a Rule 10b5-1 trading plan, reduced her ownership by 15.29%. The company recently reported strong quarterly EPS and revenue that …
Charles River Laboratories International's EVP, Shannon Parisotto, sold 3,714 shares of company stock for approximately $1.04 million, reducing her holdings by 43.59%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported adjusted earnings of $3.02 per share, exceeding estimates, …
Charles River Laboratories International Inc. (CRL) stock fell 1.09% to $281.27 on Thursday, despite a positive trading session for the broader market. This underperformance snapped a seven-day winning streak for the company's shares. The S&P 500 Index rose 0.65%, and the Dow Jones Industrial …
Michael Shafer, EVP of Thermo Fisher Scientific (NYSE:TMO), sold 25,500 shares of the company's stock for $15.3 million, reducing his direct holdings by 54.85%. This sale occurred via a pre-arranged Rule 10b5-1 trading plan. The transaction follows the company's stronger-than-expected quarterly results and a …
Thermo Fisher Scientific Inc. (TMO) saw its stock price fall by 1.18% on Thursday, closing at $595.89. This performance lagged behind the broader market, as the S&P 500 Index and the Dow Jones Industrial Average both posted gains. This marks the second consecutive day …
Charles River Laboratories (CRL) CEO Birgit Girshick exercised stock options for 6,500 shares on August 11, 2026, at an exercise price of $179.66 per share. Simultaneously, she sold these 6,500 common shares at $279.90 per share. These transactions were conducted under a pre-arranged Rule …
Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories International, exercised stock options for 3,714 shares at $179.66 per share and simultaneously sold the same number of shares at $279.66 per share. These transactions, executed on August 11, 2026, were conducted …
Artisan Partners Asset Management Inc. and its affiliates have disclosed a beneficial ownership of 4,802,017 common shares, representing a 7.7% stake, in Twist Bioscience Corporation (TWST). This position is held on behalf of Artisan Partners Limited Partnership's discretionary clients, with shared voting power over …
Michael D. Shafer, Executive Vice President at Thermo Fisher Scientific (TMO), exercised options for 25,500 shares of common stock at strike prices of $309.63 and $418.32 per share on August 11, 2026. Following the exercise, he sold all 25,500 shares at $600.00 per share, …
This article announces a manager's transaction at QIAGEN N.V. involving Eva Pisa, a member of the administrative or supervisory body. The transaction is a retroactive adjustment for a February 2026 net share settlement, withholding an additional 544 shares to cover related taxes, and is …
Qiagen (NYSE:QGEN) walked into its second quarter of 2026 bracing investors for a roughly 2% sales decline. Instead, net sales came in flat at $535 million on August 6, and adjusted diluted EPS hit $0.62, both ahead of the company's own outlook. For a …
Zillow Group (NASDAQ:Z) delivered a second quarter that beat its own outlook on nearly every line, then turned around and eliminated jobs and reshuffled its leadership team. On the call held August 5, CEO Jeremy Wacksman and newly expanded COO and CFO Jeremy Hofmann …
Invesco Ltd., a Bermuda-based parent holding company, has reported a significant passive ownership position in Charles River Laboratories International, Inc. (CRL) common stock. The firm beneficially owns 2,984,785 shares, representing 6.2% of the outstanding common stock, held by its investment advisory clients. Invesco maintains …
Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO) on the completed sale of its microbiology business to Astorg, a private equity firm, for approximately $1.075 billion. The microbiology business specializes in antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical, and food safety …
Mettler Toledo Product Inspection Group has launched LightningBuild, a program offering select product inspection systems with a four-week delivery time. This initiative includes the X12 LightningBuild X-ray inspection system and the C31 LightningBuild checkweigher, aiming to help food and pharmaceutical manufacturers quickly adapt to …
Revvity (RVTY) stock has seen a 34.1% decline over the past five years. While a Discounted Cash Flow (DCF) model suggests the shares are undervalued by 23.0% at $153 per share, earnings-based multiples indicate the stock is expensive, trading at a P/E of 55.4x …
Veracyte Inc. has launched its Prosigna Breast Risk of Recurrence (ROR) test in the U.S. This genomic assay helps patients with early-stage hormone-receptor positive breast cancer determine their 10-year risk of distant recurrence, guiding personalized treatment decisions, including whether chemotherapy will be beneficial. The …
Thermo Fisher Scientific has completed the sale of its microbiology unit to European private equity firm Astorg for $1.1 billion. The newly independent company will specialize in microbiology diagnostics, employing approximately 2,400 people across 13 global sites, and will be led by former PerkinElmer …
OPKO Health Inc. has secured $125 million in senior secured notes through an expanded financing agreement with HealthCare Royalty, a business of KKR. This financing is backed by OPKO’s royalty interests from its mazdutide license agreement with Eli Lilly and Company, with notes maturing …
Twist Bioscience stock reached a new 52-week high of $126.22, trading just 1% below this peak and marking a remarkable 440% surge from its 52-week low. The company also reported strong fiscal third-quarter 2026 revenues of $118.4 million, exceeding Wall Street estimates, although adjusted …
IQVIA Holdings stock is currently trading around $242, maintaining a market capitalization close to $40 billion, despite recent quarterly earnings showing a softer trend. Investors are focusing on the company's valuation, which includes a P/E multiple in the low 30s, and its future growth …
Search by ticker symbol or company name and select a result to open its chart.